Indeed, reduction of TGFβ signaling in the mammary gland has been associated with inappropriate differentiation and accelerated tumorigenesis in numerous models, and reduced expression of TGFβ receptors in breast cancer patients correlates with disease progression (reviewed in [5-7]). Here, TGFB1 is linked to breast carcinoma.